Company news
Lee's Pharmaceutical Holdings Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Notification Letter and Reply Form to Non-Registered Shareholders - Notice of Publication of Interim Report
September 22, 2026
Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Interim Report
September 22, 2026
Interim Report 2026
September 22, 2026
Lee's Pharmaceutical Holdings: Connected Transaction - Provision of Financial Assistance
April 28, 2021
Lee Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed from Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China
February 10, 2021
- Grant of Share Options
October 26, 2020
- Establishment of the Group Commercial Operations Centre
October 26, 2020
- Business Update on the In-Licensing and Research and Development of Ophthalmology Products of an Associated Company of the Group
October 21, 2020